Evidence reviews
The following documents contain the evidence that was used to develop the 2026 recommendations:
- Dual testing with serum CA125 and ultrasound scan compared to serum CA125 alone and age and serum CA125 thresholds for detection of suspected ovarian cancer in adults
- Technical appendices for dual testing with serum CA125 and ultrasound scan compared to serum CA125 alone and age and serum CA125 thresholds for detection of suspected ovarian cancer in adults
- Endometrial cancer: unscheduled bleeding, HRT and cancer referral
- Technical appendices for endometrial cancer: unscheduled bleeding, HRT and cancer referral
- Unexplained weight loss as a non-site specific symptom in adults in primary care
- Technical appendices for unexplained weight loss as a non-site specific symptom in adults in primary care
The following document contains the evidence that was used to develop the 2021 recommendations:
Other supporting evidence
This page was last updated: